AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Partial Meniscal Replacement with Spongioflex®

RecruitingPhase 4Ages 18 Years - 60 YearsAllMaria-Josef-Hospital Greven
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this investigator-initiated trial is to evaluate whether the novel graft can prevent/reduce the disadvantages of the previously used replacement materials and shows better results than the group of patients, which were not operated. Since there is currently no alternative made of biological material to this product, this investigator-initiated trial is of great medical and economic importance. The otherwise following arthrosis or knee prosthesis implantation (TKA ) could be prevented or at least postponed. Initial clinical results are promising. An important and sensitive parameter for assessing the postoperative function of the meniscus is the MRI image. Genovese et al. 2007 were able to show in a categorization/classification which magnetic resonance image can be expected in the case of successful incorporation. Several studies have shown that the known clinical knee sc

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients (male and female) with: 2. Partial loss of portions of the * lateral meniscus and lateral joint line pain OR * medial meniscus and medial joint line pain 3. sufficient standing of the peripheral rim, so that the procedure can be performed 4. Age: 18-60 years 5. signed written informed consent to the study and to provide the scientific data in pseudonymized form Exclusion Criteria: 1. The presence of anterior cruciate ligament insufficiency which is not resolved by reconstruction of the anterior cruciate ligament within 16 weeks after partial meniscal implantation. 2. Axial deviation (\>2° varus or valgus) 3. realignment osteotomy not performed within 12 weeks 4. advanced cartilage damage (grade III according to ICRS) and osteoarthrosis in the affected compartment (grade III according to Kellgren and Lawrence \[33\]) 5. Extension deficit of more than 3° compared to the opposite side or a knee flexion of less than 125° 6. inflammatory arthritis or synovitis on the treated knee 7. BMI greater than 30 kg/m² 8. \<18 years, \>60 years 9. Chronic pain patients 10. only for patients who will be operated: 1. with increased anaesthesiologic risk, e.g., with known or predicted difficult airway 2. with increased risk of bleeding 3. with increased risk of infection 4. with necrotic, infected, or poorly perfused host sides 5. history of allergic reactions 6. acute hypersensitivity reactions to the IMP or any of its excipients 7. pregnant woman
💊

What it tests

  • partial meniscal replacement with Spongioflex®
📍

Where

1 site
Maria-Josef-Hospital Greven GmbH
Greven, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy